[HTML][HTML] Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease in the world. Oral administration of synbiotic has been proposed as an effective
treatment of NAFLD because of its modulating effect on the gut flora, which can influence the
gut-liver axis. Objective: The objective was to evaluate the effects of supplementation with
synbiotic on hepatic fibrosis, liver enzymes, and inflammatory markers in patients with
NAFLD. Design: In a randomized, double-blind, placebo-controlled clinical trial conducted …
disease in the world. Oral administration of synbiotic has been proposed as an effective
treatment of NAFLD because of its modulating effect on the gut flora, which can influence the
gut-liver axis. Objective: The objective was to evaluate the effects of supplementation with
synbiotic on hepatic fibrosis, liver enzymes, and inflammatory markers in patients with
NAFLD. Design: In a randomized, double-blind, placebo-controlled clinical trial conducted …
以上显示的是最相近的搜索结果。 查看全部搜索结果